NEWSROOM

Pharmaceutical

PURA Aims To Modestly Extract $10 Million This Year From $18 Billion Hemp Industry Establishing A Foothold In A Much Larger Opportunity

Dallas, TX, Jan. 18, 2022 -- McapMediaWire -- Puration, Inc. (OTC Pink: PURA) today published a 2022 strategic management overview of the company’s plan for an anticipated $1 million in revenue with the potential to reach $10 million in revenue this year. The overview published today will be followed up over the next several weeks with additional management presentations covering more detail on each of the major overview components highlighted in the presentation below: Driving Demand For The...

read more

Nutra Pharma Letter to Shareholders

  Nutra Pharma has published their annual letter to shareholders to the Company’s website   Plantation, Florida, Jan. 18, 2022 -- McapMediaWire -- Nutra Pharma Corporation (OTC Pink: NPHC), a biotechnology company marketing Nyloxin®, Pet Pain-Away™, Luxury Feet™ and Equine Pain-Away™ in the over-the-counter (OTC) pain management market and which is also developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV) and Pain, announced today that the Company's...

read more

SIBANNAC, INC. AND SPUR BIOTECH, LLC ENTER LETTER OF INTENT TO MARKET PLANT BASED VACCINE

  Scottsdale, Arizona, Jan. 18, 2022  -- McapMediaWire -- Sibannac, Inc. (OTC Pink: SNNC), a Nevada corporation (the “Company”), announced the following: The Company is proud to announce the entry into a Letter of Intent with SPUR Biotech, LLC (“SPUR”), an Ohio-based developer of plant-based vaccines. SPUR is a biotechnology company developing plant-based vaccines using Controlled Environment Agriculture (CEA) to sustainably grow leafy greens and biopharmaceuticals.  The vaccine under...

read more

PURA Targets $10 Million In 2022 Revenue From New Farmersville Hemp Business

Dallas, Texas, Jan. 12, 2022  -- McapMediaWire -- Puration, Inc. (OTC Pink: PURA) today announced the company will publish a strategic overview presentation next week on Tuesday, January 18th covering the company’s 2022 plan to achieve a forecasted $1 million in revenue and reach for a potential $10 million in revenue.  The presentation will include the latest on PURA’s backing from UC Asset LP (OTCQX: UCASU) to construct the Farmersville Hemp Brand facility central to PURA’s updated business...

read more

Odyssey Group International Receives Donation to Support a Treatment for Concussion and forms Community Partnership with the Erase PTSD Now Foundation

  IRVINE, CA, Jan. 10, 2022 -- McapMediaWire -- Odyssey Group International, Inc. (OTC Pink: ODYY) (the "Company" or "Odyssey"), a company focused on developing unique, life-saving medical products, today announced that it has received a donation in the amount of $500,000 in partnership with the Erase PTSD Now organization and the Glenn Greenberg and Linda Vester Foundation. These funds will be used to progress the Phase 1 human clinical trials for drug candidate PRV-002 for the treatment...

read more

PHBI – Pharmagreen Announces Affirmed MOU To Acquire Licensed California Cannabis Company

  CARSON CITY, NV, Jan. 06, 2022 -- McapMediaWire -- Pharmagreen Biotech, Inc., (OTCQB: PHBI), today announced an affirmed  memorandum  of understanding  (MOU)  to  acquire  Long  Valley Farms LLC, a California based cannabis company. The acquisition includes land, infrastructure, and a Cannabis cultivation license for the operation of a cannabis business in the State of California. This acquisition is a strategic component of Pharmagreen’s strategy to convert the revenue potential of its...

read more

PURA Farmersville Hemp Brand Set For Growth As Institutional Investment Portfolios Expand Hemp Positions

Dallas, TX, Dec. 29, 2021  -- McapMediaWire -- Puration, Inc. (OTC Pink: PURA) today highlighted the recent Bloomberg article reporting on the investment outlook for the hemp market in 2022. Hemp Is Ready to Shine, Thanks to Plastic Bans and Carbon Caps Article highlights include: “Demand is poised to rise for hemp — the staid sister to the mood-altering forms of cannabis — as it’s increasingly adopted for a wide range of uses, including concrete blocks, clothing and even car parts. The shift...

read more

PURA Revenue Model Comes Into Focus As Company Pursues $18 Billion Hemp Market

Dallas, Texas, Dec. 16, 2021 -- McapMediaWire -- Puration, Inc. (OTC Pink: PURA) today confirmed a 2022 $1 million revenue forecast for its hemp business with a revenue upside potential to $10 million by year end 2022. PURA is targeting the industrial hemp market with a cooperative branding strategy founded largely on hemp’s potential sustainability impact. PURA has established a new business model to build an industrial hemp business with 3 sources of revenue – education, branding and...

read more

PAOG Recommends Its RelaxRX Full Spectrum CBD To Ease Stress Before Fed Decision

    Sandusky, OH, Dec. 15, 2021 -- McapMediaWire --  PAO Group, Inc. (OTC Pink: PAOG) today announced the company’s line of “RX” branded full-spectrum CBD products are now available for sale at www.usmj.com. PAOG is developing both pharmaceutical and nutraceutical treatments based on its own proprietary extraction technology. The RX branded products are PAOG’s first nutraceutical products. The RX branded products have been well received and are now available for sale direct to...

read more

PURA Sustainable Farmersville Hemp Brand Bolstered By USASU $0.10-0.15 Net Profit Per Share Projection

  Dallas, TX, Dec. 10, 2021 -- McapMediaWire - Puration, Inc. (OTC Pink: PURA) today highlighted the strength of its cannabis real estate finance partner, UC Asset LP (OTCQX: UCASU). UCASU has announced a projected $0.10 to $0.15 net profit per share to be reported for year end 2021.  UCASU is financing the construction of PURA’s hemp university facility in Farmersville, Texas and has agreed to back PURA Farmersville Hemp Brand Partners cannabis real estate projects. PURA is targeting the...

read more

PURA and PAOG Announce CBD IP Deal In Conjunction With New CBD Infused Product Developments

  Sandusky, OH, Dec. 03, 2021 -- McapMediaWire -- Puration, Inc. (OTC Pink: PURA) and PAO Group, Inc. (OTC Pink: PAOG) announced the closing of a transaction today whereby PAOG has acquired an exclusive license to a patented cannabis extraction process from PURA that will expand PAOG’s existing CBD intellectual property. Last year, PAOG acquired intellectual property derived through research into CBD extracted in association with a patented extraction method (U.S. Patent No. 9,199,960). ...

read more

PURA and PAOG Confirm CBD IP Deal Schedule To Close Friday

  Sandusky, OH, Dec. 01, 2021 -- McapMediaWire -- Puration, Inc. (OTC Pink: PURA) and PAO Group, Inc. (OTC Pink: PAOG) today confirmed the companies have finalized terms for PAOG to acquire an exclusive license to a patented cannabis extraction process from PURA that will expand the PAOG’s existing CBD intellectual property. Last year, PAOG acquired intellectual property derived through research into CBD extracted in association with a patented extraction method (U.S. Patent No....

read more

PURA Highlights Dark Horse Potential To Substantially Exceed $1M Revenue Forecast

  Dallas, Texas, Nov. 29, 2021 -- McapMediaWire -- Puration, Inc. (OTC Pink: PURA) today confirmed the company’s initial 2022 $1 million revenue forecast and reiterated the conservative nature of the forecast. “PURA’s revenue forecast is based on three sources of anticipated income,” said Brian Shibley, CEO of PURA. “We consider the $1 million revenue estimate for next year to be conservative because it is only based on one of the three sources.  I encourage people to revisit...

read more

PAOG Acquisition To Expand CBD IP Portfolio Scheduled To Close December 3rd

  Sandusky, OH, Nov. 24, 2021 -- McapMediaWire -- PAO Group, Inc. (OTC Pink: PAOG) today announced the acquisition of an exclusive license to patented cannabis extraction process that will expand the company’s existing CBD intellectual property is scheduled to close next week, on Friday, December 3rd. Last year, the company acquired intellectual property derived through research into CBD extracted in association with a patented extraction method (U.S. Patent No. 9,199,960). Now, the...

read more

PURA and PAOG Look To Tissue Culture Technology For Pharma Cannabis Cultivation

    Dallas, TX, Nov. 22, 2021 -- McapMediaWire -- Puration, Inc. (OTC Pink: PURA) and PAO Group, Inc. (OTC Pink: PAOG) today announced plans to pursue tissue culture technology for their pharmaceutical grade cannabis cultivation initiative.  A recent announcement by Pharmagreen Biotech, Inc. got the attention of the two companies. “[PHBI] is in the business of providing the highest quality starter plantlets utilizing a proprietary tissue culture process, "Chibafreen", to licensed...

read more

PURA Forecasts $1 Million 2022 Revenue From New Farmersville Hemp Brand

  Dallas, TX, Nov. 22, 2021 -- McapMediaWire -- Puration, Inc. (OTC Pink: PURA) today announced the company is initially forecasting $1 million in revenue for 2022.  Management believes the forecast is conservative and anticipates potentially revisiting the revenue forecast more than once next year. CEO Brian Shibley last week published an update outlining three target sources of revenue.  The letter has been republished below in its entirety: Dear Shareholders – We have just entered the...

read more

PAOG Announces Pending Acquisition To Expand CBD IP Portfolio Scheduled For Early December

  Sandusky, OH, Nov. 19, 2021 -- McapMediaWire --  PAO Group, Inc. (OTC Pink: PAOG) today announced the company has finalized terms for the acquisition of a license to a patented cannabis extraction process that will expand the company’s existing CBD intellectual property. Last year, the company acquired intellectual property derived through research into CBD extracted in association with a patented extraction method (U.S. Patent No. 9,199,960).  Now, the company will acquire a license to...

read more

PAOG New Pharmaceutical Product Developments Could Generate Rapid Revenue Surge

  Sandusky, OH, Nov. 17, 2021 -- McapMediaWire -- PAO Group, Inc. (OTC PINK: PAOG) today confirmed plans to add multiple new pharmaceutical products to its development pipeline in addition to its ongoing development of its RespRx CBD pharmaceutical for the treatment of Chronic Obstructive Pulmonary Disease (COPD). The company has been conducting an in-depth review of its current RespRx CBD pharmaceutical development project with its CRO partner, industry consultants and other...

read more

PAOG Expects To Soon Launch 3rd CBD Nutraceutical Adding To 2021 Revenue Potential

  Sandusky, OH, Nov. 09, 2021 -- McapMediaWire -- PAO Group, Inc. (OTC Pink: PAOG) today announced the company is on track to introduce yet a third CBD nutraceutical product by year end. PAOG recently announced the launch of its first two CBD nutraceutical products, RelaxRX CBD, a sleep aid, and RehabRX CBD, a salve. PAOG has also announced initiating a second production run of the first two CBD nutraceutical products based on the initial response to the marketing launch. PAOG has...

read more

PAOG Adds Bioidentical Synthetic CBD To Research Pipeline

  Sandusky, OH, Nov. 08, 2021 -- McapMediaWire -- PAO Group, Inc. (OTC Pink: PAOG) today announced the company adding bioidentical synthetic CBD to its overall research initiative. PAOG management highlights the fact that CBD extracted from hemp, as hemp legalization continues to evolve, has certainly brought the multitude of potential health benefits from CBD to light. PAOG has a number of both CBD pharmaceutical and nutraceutical developments under way.  Now, PAOG will add bioidentical...

read more

PAOG Announces Plans To Add New Pharmaceutical Product Developments

  Sandusky, OH, Nov. 05, 2021  -- McapMediaWire -- PAO Group, Inc. (OTC Pink: PAOG) today announced plans to add multiple new pharmaceutical products to its development pipeline in addition to its ongoing development of its RespRx CBD pharmaceutical for the treatment of Chronic Obstructive Pulmonary Disease (COPD).   PAOG (resprx.com) The company has been conducting an in-depth review of its current RespRx CBD pharmaceutical development project with its CRO partner, industry...

read more

PAOG Announces CBD Pet Product Line To Launch In December

  Sandusky, OH, Nov. 01, 2021 -- McapMediaWire -- PAO Group, Inc. (OTC Pink: PAOG) today announced the company has finalized plans to launch its CBD pet product line in December. The pet products market is estimated at over $100 billion per year. Last year, the company acquired intellectual property derived through research into CBD extracted in association with a patented extraction method (U.S. Patent No. 9,199,960). PAOG is developing both pharmaceutical and nutraceutical treatments...

read more

PAOG Entertains Partnership To Accelerate Development Of CBD Pharmaceutical Treatment For $14 Billion COPD Market

  Sandusky, OH, Oct. 28, 2021 -- McapMediaWire -- PAO Group, Inc. (OTC Pink: PAOG) today announced the company is entertaining a partnership opportunity to accelerate the ongoing development of its RespRx CBD pharmaceutical for the treatment of Chronic Obstructive Pulmonary Disease (COPD).     The COPD treatment market is anticipated to rise from an estimated $9 billion in 2015 to $14.1 billion in 2025. Last year, PAOG acquired intellectual property derived through research into...

read more

PurelyRx Launches Its Digital Pharmacy Logistics Administrative Portal Nationally

Manhattan, NY, Oct. 28, 2021 -- McapMediaWire -- Healixa, Inc. (OTC Pink: EMOR) (“Healixa”, or the “Company”), a technology company focusing on building and acquiring innovative and disruptive technologies in the health-tech, clean water, and green-tech industries, is pleased to announce that they have launched its digital pharmacy logistics administrative portal nationally through PurelyRx. PurelyRx has been laser focused on building out a unique digital pharmacy logistics application. The...

read more

Silo Pharma Enters into Sponsored Research Agreement with Columbia University to Develop Psychedelic Therapeutics for Alzheimer’s Disease

  Agreement Provides for Option to License Alzheimer’s Therapeutic   Englewood Cliffs, NJ, Oct. 27, 2021 -- McapMediaWire -- Silo Pharma, Inc. (OTCQB: SILO), a development-stage biopharmaceutical company focused on the use of psychedelics as a therapeutic, today announced that it has entered into a sponsored research agreement with Columbia University pursuant to which Silo has been granted an option to license certain assets currently under development, including Alzheimer’s...

read more

PAOG Targets First Acquisition By Year End To Accelerate 2022 Revenue Growth

  Sandusky, OH, Oct. 26, 2021 -- McapMediaWire -- PAO Group, Inc. (OTC Pink: PAOG) today announced the company’s merger and acquisition development pipeline supports plans for a first acquisition to close before the end of this year.  PAOG is actively exploring merger and acquisition opportunities targeted at expanding the company’s product line and accelerating revenue growth. The company recently announced initiating production on its first line of CBD nutraceuticals and being on track...

read more

PAOG Announces CBD “RX” Brand Introducing Second CBD Product

  Sandusky, OH, Oct. 21, 2021 -- McapMediaWire -- PAO Group, Inc. (OTC Pink: PAOG) today announced the launch of its second CBD nutraceutical product, RehabRX CBD, in a line of coming CBD products under the PAOG CBD “RX” brand name. RehabRX is a rich formulation with beneficial botanicals proven to support healthy skin. RehabRX is free from any preservatives, colors or flavorings. The CBD comes from hemp grown in the state of Colorado.  It is Gluten-free and Non-GMO. PAOG has shipped its...

read more

PAOG Scheduled To Launch 2nd CBD Nutraceutical Product This Thursday

  Sandusky, OH, Oct. 19, 2021 -- McapMediaWire -- PAO Group, Inc. (OTC Pink: PAOG) yesterday announced the launch of its first CBD nutraceutical product, RelaxRX CBD, a sleep aid. The company plans to launch its second CBD nutraceutical product on Thursday this week, October 21st, 2021. PAOG is on track to realize its first revenue this year, starting in Q4 2021, since the company acquired intellectual property derived through research into CBD extracted in association with a patented...

read more

PAOG To Launch Second CBD Nutraceutical Product Later This Week Further Ramping Up 2021 Revenue Potential

  Sandusky, OH, Oct. 18, 2021 -- McapMediaWire -- PAO Group, Inc. (OTC Pink: PAOG) earlier today announced the launch of its first CBD nutraceutical product, RelaxRX CBD, a sleep aid. The company plans to launch its second CBD nutraceutical product later this week, On Thursday, October 21st, 2021. PAOG is on track to realize its first revenue this year, starting in Q4 2021, since the company acquired intellectual property derived through research into CBD extracted in association with a...

read more

PAOG Introduces RelaxRX CBD Targeting $100 Billion Sleep Aid Market

    Sandusky, OH, Oct. 18, 2021 -- McapMediaWire -- PAO Group, Inc. (OTC Pink: PAOG) today announced the launch of its first CBD nutraceutical product, RelaxRX CBD, a sleep aid. RelaxRX is available in 30mg Softgels and in an 1800mg Tincture.  The CBD oil is 100% derived from full spectrum whole-plant hemp oil and contains no added chemicals. The sleep aid market was projected at USD 64.29 Billion in 2019 and is forecast to hit USD 101.7 Billion in 2026. PAOG has confirmed shipping...

read more

Categories

Mcap MediaWire - Costumer Service

Translate »